Status:
UNKNOWN
Effects of Cannabidiol (CBD) on the Brain
Lead Sponsor:
Auburn University
Collaborating Sponsors:
Folium Biosciences
FutureCeuticals
Conditions:
CBD
Fear
Eligibility:
All Genders
21-50 years
Phase:
NA
Brief Summary
Cannabidiol (CBD) is a phytocannabinoid that is one of 113 identified cannabinoids in the cannabis plant. It is derived from the hemp plant, and may treat conditions like pain, insomnia, and anxiety. ...
Eligibility Criteria
Inclusion
- right-handed
- between 21-50 years of age
- no current diagnosis of psychiatric or neurological conditions
- no history of heart disease or stroke
- generally healthy
- pass a screening test for the MR environment
Exclusion
- contraindications to the MR environment
- use of psychotropic or neurological medication
- history of heart disease or stroke
- diabetes or other metabolic conditions
- self-reported high blood pressure
- history of concussions
- any diagnosed psychiatric or neurological condition
- have consumed alcohol in the 24-hour period prior to a scan
- consumed pain relievers in the 12-hours prior to a scan
- consumed food or drinks (except water) and/or nicotine/caffeine an hour prior to any scanning
- have used or take THC/CBD
- exercised within an hour of a scan
Key Trial Info
Start Date :
July 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04831294
Start Date
July 15 2021
End Date
December 31 2023
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University MRI Research Center
Auburn, Alabama, United States, 36849